Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
Recruiting
Phase 1
Phase 2
Interventional Study
Keratinocyte Carcinoma
Basal Cell Carcinomas
Squamous Cell Carcinoma
Skin Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Bruce Robinson, MD · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigators seek to evaluate the effectiveness of fractional laser therapy and tirbanibulin ointment to treat squamous and basal cell carcinomas. This will be executed by using both thulium and erbium lasers on previously biopsy-confirmed SCCs and BCCs and applying bulk heating methods. Then, depending on the level of invasiveness, subjects may be instructed to apply the ointment over the co…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: biopsy confirmed squamous and/or basal cell carcinoma not previously treated by another method.
Exclusion Criteria:
* Cannot be pregnant at the time of treatment
Contacts